# Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01176318** · PHASE4 · WITHDRAWN · sponsor: **Hull University Teaching Hospitals NHS Trust**

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Erdosteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01176318
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08-10
- **Primary completion:** 2011-10-12
- **Final completion:** 2012-01-13
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** grant was withdrawn no financial support to conduct the study.
- **Last updated:** 2019-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01176318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01176318, "Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01176318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*